TABLE 6.
Individual congenital CMV infection outcomes in relation to anti-GPCMV titers
| DISC-vaccinated mother no. | Anti-GPCMV titer (titer group)a | Pups (no. live/no. dead) | No. of CMV+ pups |
|---|---|---|---|
| DISM11 | 1:160 (L) | 3/0 | 2 |
| DISM12 | 1:160 (L) | 5/0 | 0 |
| DISM6 | 1:320 (M) | 1/0 | 0 |
| DISM14 | 1:320 (M) | 4/0 | 4 |
| DISM1 | 1:640 (M) | 3/0 | 0 |
| DISM3 | 1:640 (M) | 5/0 | 0 |
| DISM5 | 1:640 (M) | 4/0 | 2 |
| DISM7 | 1:640 (M) | 4/0 | 1 |
| DISM10 | 1:640 (M) | 4/1 | 2 |
| DISM2 | 1:1,280 (H) | 3/0 | 0 |
| DISM9 | 1:1,280 (H) | 4/0 | 0 |
| DISM13 | 1:1,280 (H) | 3/2 | 1 |
| DISM8 | 1:2,560 (H) | 5/0 | 0 |
a
Anti-GPCMV titer ranges were grouped as follows: L, low (≤1:160); M, mid-range (1:320–1:640); H, high (≥1:1,280).